BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 25549791)

  • 1. Translational application of nano delivery systems: emerging cancer therapy.
    Chougule MB; Tan C
    AAPS PharmSciTech; 2015 Feb; 16(1):3-4. PubMed ID: 25549791
    [No Abstract]   [Full Text] [Related]  

  • 2. Lipid-enveloped hybrid nanoparticles for drug delivery.
    Tan S; Li X; Guo Y; Zhang Z
    Nanoscale; 2013 Feb; 5(3):860-72. PubMed ID: 23292080
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The holistic 3M modality of drug delivery nanosystems for cancer therapy.
    Sun J; Luo C; Wang Y; He Z
    Nanoscale; 2013 Feb; 5(3):845-59. PubMed ID: 23292001
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Drug self-delivery systems for cancer therapy.
    Qin SY; Zhang AQ; Cheng SX; Rong L; Zhang XZ
    Biomaterials; 2017 Jan; 112():234-247. PubMed ID: 27768976
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Multifunctional nanocarriers for simultaneous encapsulation of hydrophobic and hydrophilic drugs in cancer treatment.
    Su CW; Chiang CS; Li WM; Hu SH; Chen SY
    Nanomedicine (Lond); 2014 Jul; 9(10):1499-515. PubMed ID: 25253498
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nano-sized drug delivery systems for lymphatic delivery.
    Cho HY; Lee YB
    J Nanosci Nanotechnol; 2014 Jan; 14(1):868-80. PubMed ID: 24730304
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Editorial: Brave new world - Focus on nanomedicine.
    Alexiou C; Fadeel B
    Biochem Biophys Res Commun; 2015 Dec; 468(3):409-10. PubMed ID: 26518649
    [No Abstract]   [Full Text] [Related]  

  • 8. Nanoparticle systems reduce systemic toxicity in cancer treatment.
    Wang H; Yu J; Lu X; He X
    Nanomedicine (Lond); 2016 Jan; 11(2):103-6. PubMed ID: 26653177
    [No Abstract]   [Full Text] [Related]  

  • 9. Photosensitizing hollow nanocapsules for combination cancer therapy.
    Son KJ; Yoon HJ; Kim JH; Jang WD; Lee Y; Koh WG
    Angew Chem Int Ed Engl; 2011 Dec; 50(50):11968-71. PubMed ID: 22006833
    [No Abstract]   [Full Text] [Related]  

  • 10. Nanocarriers as an emerging platform for cancer therapy.
    Peer D; Karp JM; Hong S; Farokhzad OC; Margalit R; Langer R
    Nat Nanotechnol; 2007 Dec; 2(12):751-60. PubMed ID: 18654426
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hyaluronan nanocapsules as a new vehicle for intracellular drug delivery.
    Oyarzun-Ampuero FA; Rivera-Rodríguez GR; Alonso MJ; Torres D
    Eur J Pharm Sci; 2013 Jul; 49(4):483-90. PubMed ID: 23684914
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Carbon Nanomaterials for Drug Delivery and Cancer Therapy.
    Chakrabarti M; Kiseleva R; Vertegel A; Ray SK
    J Nanosci Nanotechnol; 2015 Aug; 15(8):5501-11. PubMed ID: 26369109
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Application of liposomal technologies for delivery of platinum analogs in oncology.
    Liu D; He C; Wang AZ; Lin W
    Int J Nanomedicine; 2013; 8():3309-19. PubMed ID: 24023517
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Glioblastoma Multiforme and Lipid Nanocapsules: A Review.
    Aparicio-Blanco J; Torres-Suárez AI
    J Biomed Nanotechnol; 2015 Aug; 11(8):1283-311. PubMed ID: 26295134
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vivo evaluation of poly-l-asparagine nanocapsules as carriers for anti-cancer drug delivery.
    Rivera-Rodriguez GR; Lollo G; Montier T; Benoit JP; Passirani C; Alonso MJ; Torres D
    Int J Pharm; 2013 Dec; 458(1):83-9. PubMed ID: 24140546
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nanomedicine for the treatment of triple-negative breast cancer.
    Kutty RV; Wei Leong DT; Feng SS
    Nanomedicine (Lond); 2014 Apr; 9(5):561-4. PubMed ID: 24827837
    [No Abstract]   [Full Text] [Related]  

  • 17. Macrophages associated with tumors as potential targets and therapeutic intermediates.
    Vinogradov S; Warren G; Wei X
    Nanomedicine (Lond); 2014 Apr; 9(5):695-707. PubMed ID: 24827844
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nanomedicine for drug targeting: strategies beyond the enhanced permeability and retention effect.
    Nehoff H; Parayath NN; Domanovitch L; Taurin S; Greish K
    Int J Nanomedicine; 2014; 9():2539-55. PubMed ID: 24904213
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interview with Professor Jindřich Kopeček.
    Kopeček J; Stanwix H
    Nanomedicine (Lond); 2014 Apr; 9(5):577-9. PubMed ID: 24827841
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Enhanced in vivo therapeutic efficacy of plitidepsin-loaded nanocapsules decorated with a new poly-aminoacid-PEG derivative.
    Lollo G; Hervella P; Calvo P; Avilés P; Guillén MJ; Garcia-Fuentes M; Alonso MJ; Torres D
    Int J Pharm; 2015 Apr; 483(1-2):212-9. PubMed ID: 25681727
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.